231 related articles for article (PubMed ID: 35143012)
1. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
Haal S; Guman MSS; Bruin S; Schouten R; van Veen RN; Fockens P; Dijkgraaf MGW; Hutten BA; Gerdes VEA; Voermans RP
Obes Surg; 2022 Apr; 32(4):1270-1278. PubMed ID: 35143012
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
[TBL] [Abstract][Full Text] [Related]
3. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
5. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
Mulliri A; Menahem B; Alves A; Dupont B
J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
[TBL] [Abstract][Full Text] [Related]
9. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
[TBL] [Abstract][Full Text] [Related]
11. Probiotics for gallstone prevention in patients with bariatric surgery: A prospective randomized trial.
Han ML; Lee MH; Lee WJ; Chen SC; Almalki OM; Chen JC; Wu CC
Asian J Surg; 2022 Dec; 45(12):2664-2669. PubMed ID: 35232647
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.
Guman MSS; Haal S; Acherman YIZ; van de Laar AWL; Nieuwdorp M; Voermans RP; Gerdes VEA
Obes Surg; 2023 Jun; 33(6):1773-1781. PubMed ID: 37186289
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
14. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: A systematic review and meta-analysis.
Choi JH; Lee SH; Cho IR; Paik WH; Ryu JK; Kim YT
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):409-418. PubMed ID: 33768730
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Alimoğulları M; Buluş H
Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
[TBL] [Abstract][Full Text] [Related]
19. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience.
Sneineh MA; Harel L; Elnasasra A; Razin H; Rotmensh A; Moscovici S; Kais H; Shirin H
Obes Surg; 2020 Mar; 30(3):846-850. PubMed ID: 31901127
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]